LABORATORY NEWS
-
IntelliGenome And NL Diagnóstica Partner To Advance Tuberculosis Detection In Brazil
IntelliGenome, Inc., a developer of CRISPR-based molecular diagnostic technologies, today announced an exclusive distribution agreement with NL Diagnóstica to advance its CRISPR-Dx™ diagnostic platform in Brazil.
- Roche Receives FDA 510(k) Clearance For New Cobas® Eplex Respiratory Pathogen Panel 3, Enabling Labs To Customize Respiratory Testing For Local Patient Needs
- Transforming Data Into Actionable Insights In The Lab
- Golden LEAF Helps ECU Grow Pipeline Of Clinical Laboratory Scientists
- Ozelle To Spotlight Scalable AI-Assisted Hematology With O-Cyte 1 At MEDICA 2026
ARCHIVED NEWSLETTER
- 10.06.26 -- QIAGEN Launches QIAmini To Automate Small-Batch Sample Preparation
- 09.22.26 -- Sakura Finetek Europe Launches Sakura Pathology Network
- 08.25.26 -- GHK-Cu Peptide Launched By Kylo Peptides For Laboratory Research Applications
- 07.21.26 -- Reassessing Nanoparticle Immunotoxicity: From Well-Established To Novel Approaches
- 07.07.26 -- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis